August 2026: A cross-section of recent ICGEB scientific publications.
Read More


Cellular Immunology Lab led by Federica Benvenuti contributes to landmark Science study revealing how the body’s first line of defence prepares anti-cancer immunity
Read More

Published in Science: an international study reveals how mechanical forces in cardiac tissue inhibit cancer cell proliferation
Read More

International partnership between ICGEB and the Hungarian Center of Excellence for Molecular Medicine promises stronger and more effective responses to the challenges of aging and cancer.
Read More
Researchers at ICGEB Trieste contribute to a collaborative study on integrated bioengineering and cell therapy techniques to preserve the fertility of pediatric cancer patients.
Read More
From a Metabolite-based resistance mechanism against Malaria published in Science to the Springer Nature Editor Distinction Award: a quarterly round-up of scientific highlights from the ICGEB.
Read More
Significant funding has been awarded to ICGEB Principal Investigators Dr. Federica Benvenuti, and Prof. Giannino Del Sal for their research into cancer.
Read More
In East Africa, which covers 50% of the population of the Continent, the major cause of cancer deaths in women is HPV-induced cervical cancer.
Read More
13 marzo 2024: Nuove prospettive per l’immunoterapia dei tumori polmonari emergono dai dati appena pubblicati, sulla prestigiosa rivista Nature Communications, dal gruppo di ricerca diretto dalla Dr. Federica Benvenuti presso l’ICGEB di Trieste.
Read More
March 13, 2024: New perspectives for lung cancer immunotherapy emerge from data just published, in the prestigious journal Nature Communications, by the research group led by Dr. Federica Benvenuti at the ICGEB in Trieste, Italy. The study was supported by AIRC Foundation for Cancer Research.
Read More